Applied Biomics Launches New Antigen Affinity Purified HCP Antibody with 95% Coverage
June 24, 2026
HAYWARD, Calif. -- Applied Biomics, Inc., a leading provider of Host Cell Protein (HCP) products and HCP services, today announced the new Antigen Affinity Purified HCP Antibodies. The new product line expands the company's portfolio of high-performance HCP antibody solutions for use in biopharmaceutical process development and quality control. Unlike conventional antigen affinity-purified antibodies, which often recognize only a [...]
June 24, 2026
ANKENY, Iowa — Proliant Health & Biologicals, a global leader in purified proteins, today announced the commercial launch of AlbufreeDX, a recombinant human albumin (rHA) designed to meet the growing demand for high-performance, animal-free ingredients across diagnostic and life science applications. For more than two decades, Proliant has been a trusted manufacturer of albumin and other [...]
LabCycle receives £180k funding to tackle laboratory plastic waste
June 23, 2026
Bath-based startup, LabCycle, has received £180,000 in funding from the British Design Fund (BDF) to support the development of its ‘world’s first’ AutoDecon system, designed to safely recycle contaminated laboratory plastics into high‑grade resources without high heat or pressure. The investment is part of a broader funding round, alongside a £250,000 Innovate UK Investment Partnership grant [...]
Daniel M. Skovronsky, MD, PhD, appointed to Illumina’s Board of Directors
June 23, 2026
Eli Lilly and Company's Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina's Board SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky brings extensive experience in drug discovery, clinical development and [...]
VectorBuilder Partners with MaxCyte® to Advance Clinical-Grade Cell Engineering
June 23, 2026
The next-generation platform integrates VectorBuilder’s regulatory-compliant gene delivery technology with MaxCyte’s clinically validated electroporation platform to enable robust, scalable, and reliable clinical-grade cell engineering. Chicago, IL & Rockville, MD – VectorBuilder, a global leader in gene delivery technologies and CDMO services, and MaxCyte, a leading, cell-engineering company providing enabling platform technologies to advance the discovery, development, [...]
NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
June 23, 2026
News Summary: Industry and research leaders including Dassault Systèmes, Databricks, Lilly, Schrödinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent Toolkit to bring agentic life sciences workflows to researchers and scientists. NVIDIA BioNeMo Agent Toolkit — including NVIDIA Nemotron, NemoClaw, OpenShell [...]
HighRes® and Waters Collaborate to Advance Drug Discovery through Robotic Automation
June 23, 2026
BEVERLY, Mass. -- HighRes® today announced a strategic collaboration to enable robotic capabilities on Waters Biosciences, formerly BD Biosciences, flow cytometers to automate key experimental steps and streamline research workflows, from basic research to drug discovery. The companies are integrating the BD FACSLyric™ Flow Cytometer1 with the HighRes Nucleus® Automation and Cellario® Software Platforms, enabling [...]
Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit
June 23, 2026
New capabilities connect AI agents, scientific literature, and validated computational engines to accelerate model-informed drug development RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that helps advance biopharma innovation, today announced it is building the agentic layer of Composer, [...]
June 23, 2026
Cellario OS™ is the open, instrument-agnostic execution layer that turns experiments from any AI Scientist into validated, provenance-rich laboratory data, completing the loop between AI-driven hypothesis and real-world result. BEVERLY, Mass. -- HighRes® today announced that its Cellario OS™ lab orchestration platform serves as the open execution layer for AI Scientists, both autonomous agents and AI-enabled [...]
June 23, 2026
Applications include structure research and operando studies of new materials for manganese-rich, sodium-ion, and all-solid-state batteries. CRANS-MONTANA, Switzerland – Bruker today at the EPDIC 2026 announced the launch of the D8 ADVANCE HE and D8 DISCOVER HE, new X-ray diffraction systems specifically optimized for High-Energy X-Ray Diffraction (HE-XRD), expanding the ability of researchers to capture higher real-space resolution, extended [...]

